Vitamin D3 24-hydroxylase mRNA expression in the skin of calcipotriol-treated psoriatic patients correlates with clinical efficacy.
D002117:Calcitriol / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D003879:Dermatologic Agents / Q000008:administration & dosage*; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy* / Q000503:physiopathology*; D012333:RNA, Messenger / Q000032:analysis; D012867:Skin / Q000187:drug effects* / Q000201:enzymology; D013250:Steroid Hydroxylases / Q000235:genetics*; D016896:Treatment Outcome; D065668:Vitamin D3 24-Hydroxylase
D003879:Dermatologic Agents; D012333:RNA, Messenger; C055085:calcipotriene; D003577:Cytochrome P-450 Enzyme System; D013250:Steroid Hydroxylases; D065668:Vitamin D3 24-Hydroxylase; D002117:Calcitriol